|
ZNF543 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.94200000000522E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.92690000000639E-05 |
| Normal-vs-Stage2 |
9.700300E-03 |
| Normal-vs-Stage3 |
5.929800E-02 |
| Normal-vs-Stage4 |
1.555200E-01 |
| Stage1-vs-Stage2 |
9.299600E-01 |
| Stage1-vs-Stage3 |
8.254400E-01 |
| Stage1-vs-Stage4 |
9.523600E-01 |
| Stage2-vs-Stage3 |
8.186600E-01 |
| Stage2-vs-Stage4 |
9.976600E-01 |
| Stage3-vs-Stage4 |
8.713800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.043240E-04 |
| Normal-vs-AfricanAmerican |
2.844800E-03 |
| Normal-vs-Asian |
2.796200E-03 |
| Caucasian-vs-AfricanAmerican |
8.180200E-01 |
| Caucasian-vs-Asian |
4.921800E-01 |
| AfricanAmerican-vs-Asian |
4.032800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.48250000018425E-07 |
| Normal-vs-Female |
4.508600E-01 |
| Male-vs-Female |
1.557030E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.721400E-03 |
| Normal-vs-Extreme_Weight |
1.0207999999734E-06 |
| Normal-vs-Obese |
7.150500E-02 |
| Normal-vs-Extreme_Obese |
2.466200E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.654200E-01 |
| Normal_Weight-vs-Obese |
3.763000E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.894800E-01 |
| Extreme_Weight-vs-Obese |
3.108200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.681800E-01 |
| Obese-vs-Extreme_Obese |
2.605200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.035200E-01 |
| Normal-vs-Age(41-60Yrs) |
7.098500E-03 |
| Normal-vs-Age(61-80Yrs) |
6.40660000050808E-07 |
| Normal-vs-Age(81-100Yrs) |
1.73851999999419E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.756800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.440400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.037800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.223600E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.668200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.773800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.85720000000145E-05 |
| Normal-VS-Type2 PRCC |
4.07080000042193E-07 |
| Normal-VS-KIRP CIMP |
3.891800E-01 |
| Normal-VS-Unclassified PRCC |
1.533400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.825900E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.064570E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.079230E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.827600E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.677400E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
2.133000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.91150000050655E-07 |
| Normal-vs-N1 |
9.415600E-01 |
| Normal-vs-N2 |
7.524000E-02 |
| N0-vs-N1 |
4.081900E-02 |
| N0-vs-N2 |
6.191000E-01 |
| N1-vs-N2 |
5.091600E-01 |
|
|
